Full symptom control in patients with allergic rhinoconjunctivitis caused by grass pollen - results of a 2-year sublingual allergen immunotherapy study

被引：0
|
作者：
Karagiannis, E. [1 ]
Hadler, M. [1 ]
Shah-Hosseini, K. [2 ]
Titova, K. [2 ]
Moesges, R. [2 ]
机构：
[1] Stallergenes GmbH, Kamp Lintfort, Germany
[2] Univ Cologne, IMSIE, D-50931 Cologne, Germany
来源：
ALLERGY | 2013年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：553 / 554
页数：2
相关论文
共 50 条
  • [1] Effectiveness and tolerability of a 2-year sublingual allergen immunotherapy (AIT) in children and adolescents allergic rhinoconjunctivitis caused by birch pollen
    Karagiannis, E.
    Shah-Hosseini, K.
    Hadler, M.
    Moesges, R.
    ALLERGY, 2014, 69 : 186 - 187
  • [2] Non-interventional 2-year-study of sublingual immunotherapy (SLIT) in patients with allergic rhinoconjunctivitis caused by grass pollen
    Karagiannis, E.
    Hadler, M.
    Shah-Hosseini, K.
    Titova, K.
    Moesges, R.
    ALLERGY, 2013, 68 : 482 - 482
  • [3] Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen
    Skoner, David
    Gentile, Deborah
    Bush, Robert
    Fasano, Mary Beth
    McLaughlin, Anne
    Esch, Robert E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (03) : 660 - 666
  • [4] Efficacy of sublingual allergen immunotherapy tablets on individual symptom scores in adults with grass pollen-induced allergic rhinoconjunctivitis
    Didier, A.
    Horak, F.
    Worm, M.
    Melac, M.
    de Beaumont, O.
    Le Gall, M.
    Montagut, A.
    Galvain, S.
    Malling, H.
    ALLERGY, 2011, 66 : 63 - 63
  • [5] Oralair®: sublingual immunotherapy for the treatment of grass pollen allergic rhinoconjunctivitis
    Hong, Jison
    Bielory, Leonard
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (04) : 437 - 444
  • [6] Full symptom control in patients with allergic rhinoconjunctivitis induced by birch pollen treated with sublingual allergen immunotherapy (AIT) in real-life medical practice
    Hadler, M.
    Karagiannis, E.
    Shah-Hosseini, K.
    Moesges, R.
    ALLERGY, 2014, 69 : 509 - 509
  • [7] Relapse of allergic rhinoconjunctivitis after completion of 3 year course of grass pollen sublingual immunotherapy
    Grewal, Anjum
    Jay, Nicola
    CLINICAL AND EXPERIMENTAL ALLERGY, 2018, 48 (11): : 1557 - 1557
  • [8] Sublingual five-grass pollen tablets (Oralair®): A guide to their use as allergen immunotherapy for grass pollen-induced allergic rhinoconjunctivitis
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2014, 30 (6) : 200 - 208
  • [9] Effectiveness and tolerability of a 2-year sublingual allergen immunotherapy in routine medical practice in birch pollen allergic patients
    Hadler, M.
    Karagiannis, E.
    Shah-Hosseini, K.
    Moesges, R.
    ALLERGY, 2013, 68 : 483 - 483
  • [10] Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis
    Dahl, Ronald
    Kapp, Alexander
    Colombo, Giselda
    deMonchy, Jan G. R.
    Rak, Sabina
    Emminger, Waltraud
    Rivas, Montserrat Fernandez
    Ribel, Mette
    Durham, Stephen R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (02) : 434 - 440
12345